34 related articles for article (PubMed ID: 7506579)
1. A method for the preparation of DNA from calf thymus nuclei in maximum purity and yield, analysis of this DNA compared with that obtained by other methods.
Welsh RS
Physiol Chem Phys Med NMR; 1993; 25(2):125-35. PubMed ID: 8378439
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral Vector Bioprocessing.
Perry C; Rayat ACME
Viruses; 2021 Feb; 13(2):. PubMed ID: 33572347
[TBL] [Abstract][Full Text] [Related]
3. Improving the Transduction of Bone Marrow-Derived Cells with an Integrase-Defective Lentiviral Vector.
Pay SL; Qi X; Willard JF; Godoy J; Sankhavaram K; Horton R; Mitter SK; Quigley JL; Chang LJ; Grant MB; Boulton ME
Hum Gene Ther Methods; 2018 Feb; 29(1):44-59. PubMed ID: 29160102
[TBL] [Abstract][Full Text] [Related]
4. Scalable downstream strategies for purification of recombinant adeno- associated virus vectors in light of the properties.
Qu W; Wang M; Wu Y; Xu R
Curr Pharm Biotechnol; 2015; 16(8):684-95. PubMed ID: 25941887
[TBL] [Abstract][Full Text] [Related]
5. Engineering a serum-resistant and thermostable vesicular stomatitis virus G glycoprotein for pseudotyping retroviral and lentiviral vectors.
Hwang BY; Schaffer DV
Gene Ther; 2013 Aug; 20(8):807-15. PubMed ID: 23364315
[TBL] [Abstract][Full Text] [Related]
6. Complementation cell lines for viral vectors to be used in gene therapy.
Mehtali M
Cytotechnology; 1995 Jan; 19(1):43-54. PubMed ID: 22358904
[TBL] [Abstract][Full Text] [Related]
7. Downstream processing of cell culture-derived virus particles.
Wolf MW; Reichl U
Expert Rev Vaccines; 2011 Oct; 10(10):1451-75. PubMed ID: 21988309
[TBL] [Abstract][Full Text] [Related]
8. Tagging retrovirus vectors with a metal binding peptide and one-step purification by immobilized metal affinity chromatography.
Ye K; Jin S; Ataai MM; Schultz JS; Ibeh J
J Virol; 2004 Sep; 78(18):9820-7. PubMed ID: 15331716
[TBL] [Abstract][Full Text] [Related]
9. Infectious entry by amphotropic as well as ecotropic murine leukemia viruses occurs through an endocytic pathway.
Katen LJ; Januszeski MM; Anderson WF; Hasenkrug KJ; Evans LH
J Virol; 2001 Jun; 75(11):5018-26. PubMed ID: 11333881
[TBL] [Abstract][Full Text] [Related]
10. Toward a more accurate quantitation of the activity of recombinant retroviruses: alternatives to titer and multiplicity of infection.
Andreadis S; Lavery T; Davis HE; Le Doux JM; Yarmush ML; Morgan JR
J Virol; 2000 Feb; 74(3):1258-66. PubMed ID: 10627536
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous infection with retroviruses pseudotyped with different envelope proteins bypasses viral receptor interference associated with colocalization of gp70 and target cells on fibronectin CH-296.
MacNeill EC; Hanenberg H; Pollok KE; van der Loo JC; Bierhuizen MF; Wagemaker G; Williams DA
J Virol; 1999 May; 73(5):3960-7. PubMed ID: 10196291
[TBL] [Abstract][Full Text] [Related]
12. Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5 to 7.5 hours.
Andreadis ST; Brott D; Fuller AO; Palsson BO
J Virol; 1997 Oct; 71(10):7541-8. PubMed ID: 9311834
[TBL] [Abstract][Full Text] [Related]
13. Optimization of environmental factors for the production and handling of recombinant retrovirus.
Lee SG; Kim S; Robbins PD; Kim BG
Appl Microbiol Biotechnol; 1996 May; 45(4):477-83. PubMed ID: 8737571
[TBL] [Abstract][Full Text] [Related]
14. Proteoglycans secreted by packaging cell lines inhibit retrovirus infection.
Le Doux JM; Morgan JR; Snow RG; Yarmush ML
J Virol; 1996 Sep; 70(9):6468-73. PubMed ID: 8709284
[TBL] [Abstract][Full Text] [Related]
15. A rapid and efficient method for concentration of small volumes of retroviral supernatant.
Miller DL; Meikle PJ; Anson DS
Nucleic Acids Res; 1996 Apr; 24(8):1576-7. PubMed ID: 8628695
[No Abstract] [Full Text] [Related]
16. Retrovirus infection: effect of time and target cell number.
Morgan JR; LeDoux JM; Snow RG; Tompkins RG; Yarmush ML
J Virol; 1995 Nov; 69(11):6994-7000. PubMed ID: 7474118
[TBL] [Abstract][Full Text] [Related]
17. Increased viral titer through concentration of viral harvests from retroviral packaging lines.
Paul RW; Morris D; Hess BW; Dunn J; Overell RW
Hum Gene Ther; 1993 Oct; 4(5):609-15. PubMed ID: 7506579
[TBL] [Abstract][Full Text] [Related]
18. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene.
Persons DA; Mehaffey MG; Kaleko M; Nienhuis AW; Vanin EF
Blood Cells Mol Dis; 1998 Jun; 24(2):167-82. PubMed ID: 9642098
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S
Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
